Short Term Trading Week Starting: 5 Mar, page-144

STTCOMP IMU, TA Long.
IMUGENE  LTD
biotech
SP 0.023
Market Cap $68 mil
Cash $12 mil

Imugene Limited (IMU) is an Australian immuno-oncology focused Biopharmaceutical
Company developing HER2 + ve gastric and breast cancer vaccines. The Group s
lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates
a polyclonal antibody response to HER2/neu.

ascending triangle breakout looming perhaps

volume decreasing during formation

initial target .034

also been a lot of orders around and over $100,000 recently








and looking good on the monthly too